<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05084274</url>
  </required_header>
  <id_info>
    <org_study_id>LSPCOLMMDV</org_study_id>
    <nct_id>NCT05084274</nct_id>
  </id_info>
  <brief_title>Optimising Preconceptual Health in Subfertile PCOS Patients Using a Lifestyle Modification Program</brief_title>
  <official_title>Optimising Preconceptual Health in Subfertile PCOS Patients. Implementation of a Lifestyle Modification Program Before Fertility Treatment, Impact on Health Related Quality of Life and Obstetric Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients will be randomly assigned to a group where they undergo a 12-week lifestyle&#xD;
      modification program prior to their fertility treatment, or a group where they are entitled&#xD;
      to start their fertility treatment without prior lifestyle modification program.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      When allocated to the control arm patients will receive the standard of care combined with&#xD;
      the foreseen questionnaires and bio-electric impedance analysis for body composition and&#xD;
      ergospirometry. When the patient is allocated to the interventional arm she will receive a&#xD;
      12-week lifestyle modification program prior to her fertility treatment. The lifestyle&#xD;
      modification program will consist of dietary advice, advice for physical activity and&#xD;
      emotional support. After the 12-week program the fertilty treatment will start as per routine&#xD;
      practice. Questionnaires, ergospirometry and bio-electric impedance analysis will also be&#xD;
      performed at the foreseen moments.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 10, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>body weight</measure>
    <time_frame>12 weeks after start of intervention</time_frame>
    <description>body weight (kg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>body composition</measure>
    <time_frame>12 weeks after start of intervention</time_frame>
    <description>body composition (Total Body Fat and Fat Free Mass), measured by using bio-electric im-pedance analysis (BIA)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">226</enrollment>
  <condition>Infertility, Female</condition>
  <condition>Polycystic Ovarian Syndrome</condition>
  <condition>Lifestyle</condition>
  <arm_group>
    <arm_group_label>Lifestyle intervention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12-week lifestyle modification programme through face-to-face lifestyle counseling and physiotherapy combined with a follow-up programme using video consultations and online training sessions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard-of-care group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle program</intervention_name>
    <description>If the patient is allocated to the interventional group, the lifestyle modification program will be planned/started immediately after the intake at the fertility clinic. The lifestyle modification program has a duration of 12 weeks in which the subject will receive follow-up by the endocrinologist/diabetologist and dietitian to re-ceive an active dietary intervention plan, follow-up by the physiotherapist where sessions to start with physical exercise will be given. Monthly follow-up visits with the coordinating PCOS-midwife will be planned to enhance the subject's knowledge about PCOS and give emotional support. At the moment of randomization, the PCOS coordinating midwife will immediately plan all necessary appointments, with the endocrinologist and dietitian, physiotherapist and PCOS-coordinator, for the 12-week lifestyle program. This way, patients will have a clear overview of the following 12 weeks.</description>
    <arm_group_label>Lifestyle intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subfertile patients between &gt;18- &lt;38 years old requesting fertility treatment at our&#xD;
             centre&#xD;
&#xD;
          -  PCOS phenotypes A, B, C and D according to the NIH 2012 extension of the ESHRE/ASRM&#xD;
             2003 diagnostic criteria&#xD;
&#xD;
          -  BMI &gt;27 and &lt;38 (Jiskoot et al. 2017)&#xD;
&#xD;
          -  Nulliparous women&#xD;
&#xD;
          -  Patient gives consent voluntarily&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients will be excluded if they:&#xD;
&#xD;
          -  do not meet the ESHRE/ASRM 2003 diagnostic PCOS criteria&#xD;
&#xD;
          -  Have a BMI &lt;27 and &gt;38 (Jiskoot et al. 2017)&#xD;
&#xD;
          -  Need Surgical sperm retrieval&#xD;
&#xD;
          -  Use donor eggs&#xD;
&#xD;
          -  Need Pre-implantation genetic testing (PGT)&#xD;
&#xD;
          -  Multiparous women&#xD;
&#xD;
          -  cannot reliably fill out the questionnaires or comprehend the intervention, because of&#xD;
             a language barrier&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel De Vos</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitair Ziekenhuis Brussel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michel De Vos, PhD</last_name>
    <phone>+3224776648</phone>
    <email>mdevos@uzbrussel.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Linde De Vos</last_name>
    <phone>+3224776648</phone>
    <email>linde.mostinckx@uzbrussel.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel</name>
      <address>
        <city>Brussel</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linde Mostinckx</last_name>
      <email>Linde.Mostinckx@uzbrussel.be</email>
    </contact>
    <contact_backup>
      <last_name>Elsie Nulens</last_name>
      <email>Elsie.nulens@uzbrussel.be</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2021</study_first_posted>
  <last_update_submitted>October 6, 2021</last_update_submitted>
  <last_update_submitted_qc>October 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

